Global Biomarker Clinical Phase Outsourcing Services Market Growth (Status and Outlook) 2026-2032
The global Biomarker Clinical Phase Outsourcing Services market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
United States market for Biomarker Clinical Phase Outsourcing Services is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Biomarker Clinical Phase Outsourcing Services is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Biomarker Clinical Phase Outsourcing Services is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Biomarker Clinical Phase Outsourcing Services players cover ICON plc, Fujirebio lnc, Charles River Laboratories International,Inc., Laboratory Corporation of America Holdings, Parexel lnternational Corporation, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the ?Biomarker Clinical Phase Outsourcing Services Industry Forecast? looks at past sales and reviews total world Biomarker Clinical Phase Outsourcing Services sales in 2025, providing a comprehensive analysis by region and market sector of projected Biomarker Clinical Phase Outsourcing Services sales for 2026 through 2032. With Biomarker Clinical Phase Outsourcing Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biomarker Clinical Phase Outsourcing Services industry.
This Insight Report provides a comprehensive analysis of the global Biomarker Clinical Phase Outsourcing Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Biomarker Clinical Phase Outsourcing Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Biomarker Clinical Phase Outsourcing Services market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biomarker Clinical Phase Outsourcing Services and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biomarker Clinical Phase Outsourcing Services.
This report presents a comprehensive overview, market shares, and growth opportunities of Biomarker Clinical Phase Outsourcing Services market by product type, application, key players and key regions and countries.
Segmentation by Type:
United States market for Biomarker Clinical Phase Outsourcing Services is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Biomarker Clinical Phase Outsourcing Services is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Biomarker Clinical Phase Outsourcing Services is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Biomarker Clinical Phase Outsourcing Services players cover ICON plc, Fujirebio lnc, Charles River Laboratories International,Inc., Laboratory Corporation of America Holdings, Parexel lnternational Corporation, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the ?Biomarker Clinical Phase Outsourcing Services Industry Forecast? looks at past sales and reviews total world Biomarker Clinical Phase Outsourcing Services sales in 2025, providing a comprehensive analysis by region and market sector of projected Biomarker Clinical Phase Outsourcing Services sales for 2026 through 2032. With Biomarker Clinical Phase Outsourcing Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biomarker Clinical Phase Outsourcing Services industry.
This Insight Report provides a comprehensive analysis of the global Biomarker Clinical Phase Outsourcing Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Biomarker Clinical Phase Outsourcing Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Biomarker Clinical Phase Outsourcing Services market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biomarker Clinical Phase Outsourcing Services and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biomarker Clinical Phase Outsourcing Services.
This report presents a comprehensive overview, market shares, and growth opportunities of Biomarker Clinical Phase Outsourcing Services market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Predictive Biomarker
- Prognostic Biomarker
- Safety Biomarker
- Surrogate Endpoints
- Pharmaceutical Companies
- Biotechnology Companies
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- ICON plc
- Fujirebio lnc
- Charles River Laboratories International,Inc.
- Laboratory Corporation of America Holdings
- Parexel lnternational Corporation
- Proteome Sciences plc
- Eurofins Scientific
- Wuxi AppTec Co., Ltd.
- NorthEast BioAnalytical Laboratories LLC.
- Celerion, Inc.
- GenScript ProBio Co.,Ltd.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Biomarker Clinical Phase Outsourcing Services Market Size (2021-2032)
2.1.2 Biomarker Clinical Phase Outsourcing Services Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Biomarker Clinical Phase Outsourcing Services by Country/Region (2021, 2025 & 2032)
2.2 Biomarker Clinical Phase Outsourcing Services Segment by Type
2.2.1 Predictive Biomarker
2.2.2 Prognostic Biomarker
2.2.3 Safety Biomarker
2.2.4 Surrogate Endpoints
2.2.5 Biomarker Clinical Phase Outsourcing Services Market Size by Type
2.2.5.1 Biomarker Clinical Phase Outsourcing Services Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.5.2 Global Biomarker Clinical Phase Outsourcing Services Market Size Market Share by Type (2021-2026)
2.3 Biomarker Clinical Phase Outsourcing Services Segment by Application
2.3.1 Pharmaceutical Companies
2.3.2 Biotechnology Companies
2.3.3 Others
2.3.4 Biomarker Clinical Phase Outsourcing Services Market Size by Application
2.3.4.1 Biomarker Clinical Phase Outsourcing Services Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Biomarker Clinical Phase Outsourcing Services Market Size Market Share by Application (2021-2026)
3 BIOMARKER CLINICAL PHASE OUTSOURCING SERVICES MARKET SIZE BY PLAYER
3.1 Biomarker Clinical Phase Outsourcing Services Market Size Market Share by Player
3.1.1 Global Biomarker Clinical Phase Outsourcing Services Revenue by Player (2021-2026)
3.1.2 Global Biomarker Clinical Phase Outsourcing Services Revenue Market Share by Player (2021-2026)
3.2 Global Biomarker Clinical Phase Outsourcing Services Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 BIOMARKER CLINICAL PHASE OUTSOURCING SERVICES BY REGION
4.1 Biomarker Clinical Phase Outsourcing Services Market Size by Region (2021-2026)
4.2 Global Biomarker Clinical Phase Outsourcing Services Annual Revenue by Country/Region (2021-2026)
4.3 Americas Biomarker Clinical Phase Outsourcing Services Market Size Growth (2021-2026)
4.4 APAC Biomarker Clinical Phase Outsourcing Services Market Size Growth (2021-2026)
4.5 Europe Biomarker Clinical Phase Outsourcing Services Market Size Growth (2021-2026)
4.6 Middle East & Africa Biomarker Clinical Phase Outsourcing Services Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Biomarker Clinical Phase Outsourcing Services Market Size by Country (2021-2026)
5.2 Americas Biomarker Clinical Phase Outsourcing Services Market Size by Type (2021-2026)
5.3 Americas Biomarker Clinical Phase Outsourcing Services Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biomarker Clinical Phase Outsourcing Services Market Size by Region (2021-2026)
6.2 APAC Biomarker Clinical Phase Outsourcing Services Market Size by Type (2021-2026)
6.3 APAC Biomarker Clinical Phase Outsourcing Services Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Biomarker Clinical Phase Outsourcing Services Market Size by Country (2021-2026)
7.2 Europe Biomarker Clinical Phase Outsourcing Services Market Size by Type (2021-2026)
7.3 Europe Biomarker Clinical Phase Outsourcing Services Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Biomarker Clinical Phase Outsourcing Services by Region (2021-2026)
8.2 Middle East & Africa Biomarker Clinical Phase Outsourcing Services Market Size by Type (2021-2026)
8.3 Middle East & Africa Biomarker Clinical Phase Outsourcing Services Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL BIOMARKER CLINICAL PHASE OUTSOURCING SERVICES MARKET FORECAST
10.1 Global Biomarker Clinical Phase Outsourcing Services Forecast by Region (2027-2032)
10.1.1 Global Biomarker Clinical Phase Outsourcing Services Forecast by Region (2027-2032)
10.1.2 Americas Biomarker Clinical Phase Outsourcing Services Forecast
10.1.3 APAC Biomarker Clinical Phase Outsourcing Services Forecast
10.1.4 Europe Biomarker Clinical Phase Outsourcing Services Forecast
10.1.5 Middle East & Africa Biomarker Clinical Phase Outsourcing Services Forecast
10.2 Americas Biomarker Clinical Phase Outsourcing Services Forecast by Country (2027-2032)
10.2.1 United States Market Biomarker Clinical Phase Outsourcing Services Forecast
10.2.2 Canada Market Biomarker Clinical Phase Outsourcing Services Forecast
10.2.3 Mexico Market Biomarker Clinical Phase Outsourcing Services Forecast
10.2.4 Brazil Market Biomarker Clinical Phase Outsourcing Services Forecast
10.3 APAC Biomarker Clinical Phase Outsourcing Services Forecast by Region (2027-2032)
10.3.1 China Biomarker Clinical Phase Outsourcing Services Market Forecast
10.3.2 Japan Market Biomarker Clinical Phase Outsourcing Services Forecast
10.3.3 Korea Market Biomarker Clinical Phase Outsourcing Services Forecast
10.3.4 Southeast Asia Market Biomarker Clinical Phase Outsourcing Services Forecast
10.3.5 India Market Biomarker Clinical Phase Outsourcing Services Forecast
10.3.6 Australia Market Biomarker Clinical Phase Outsourcing Services Forecast
10.4 Europe Biomarker Clinical Phase Outsourcing Services Forecast by Country (2027-2032)
10.4.1 Germany Market Biomarker Clinical Phase Outsourcing Services Forecast
10.4.2 France Market Biomarker Clinical Phase Outsourcing Services Forecast
10.4.3 UK Market Biomarker Clinical Phase Outsourcing Services Forecast
10.4.4 Italy Market Biomarker Clinical Phase Outsourcing Services Forecast
10.4.5 Russia Market Biomarker Clinical Phase Outsourcing Services Forecast
10.5 Middle East & Africa Biomarker Clinical Phase Outsourcing Services Forecast by Region (2027-2032)
10.5.1 Egypt Market Biomarker Clinical Phase Outsourcing Services Forecast
10.5.2 South Africa Market Biomarker Clinical Phase Outsourcing Services Forecast
10.5.3 Israel Market Biomarker Clinical Phase Outsourcing Services Forecast
10.5.4 Turkey Market Biomarker Clinical Phase Outsourcing Services Forecast
10.6 Global Biomarker Clinical Phase Outsourcing Services Forecast by Type (2027-2032)
10.7 Global Biomarker Clinical Phase Outsourcing Services Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Biomarker Clinical Phase Outsourcing Services Forecast
11 KEY PLAYERS ANALYSIS
11.1 ICON plc
11.1.1 ICON plc Company Information
11.1.2 ICON plc Biomarker Clinical Phase Outsourcing Services Product Offered
11.1.3 ICON plc Biomarker Clinical Phase Outsourcing Services Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 ICON plc Main Business Overview
11.1.5 ICON plc Latest Developments
11.2 Fujirebio lnc
11.2.1 Fujirebio lnc Company Information
11.2.2 Fujirebio lnc Biomarker Clinical Phase Outsourcing Services Product Offered
11.2.3 Fujirebio lnc Biomarker Clinical Phase Outsourcing Services Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Fujirebio lnc Main Business Overview
11.2.5 Fujirebio lnc Latest Developments
11.3 Charles River Laboratories International,Inc.
11.3.1 Charles River Laboratories International,Inc. Company Information
11.3.2 Charles River Laboratories International,Inc. Biomarker Clinical Phase Outsourcing Services Product Offered
11.3.3 Charles River Laboratories International,Inc. Biomarker Clinical Phase Outsourcing Services Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Charles River Laboratories International,Inc. Main Business Overview
11.3.5 Charles River Laboratories International,Inc. Latest Developments
11.4 Laboratory Corporation of America Holdings
11.4.1 Laboratory Corporation of America Holdings Company Information
11.4.2 Laboratory Corporation of America Holdings Biomarker Clinical Phase Outsourcing Services Product Offered
11.4.3 Laboratory Corporation of America Holdings Biomarker Clinical Phase Outsourcing Services Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Laboratory Corporation of America Holdings Main Business Overview
11.4.5 Laboratory Corporation of America Holdings Latest Developments
11.5 Parexel lnternational Corporation
11.5.1 Parexel lnternational Corporation Company Information
11.5.2 Parexel lnternational Corporation Biomarker Clinical Phase Outsourcing Services Product Offered
11.5.3 Parexel lnternational Corporation Biomarker Clinical Phase Outsourcing Services Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Parexel lnternational Corporation Main Business Overview
11.5.5 Parexel lnternational Corporation Latest Developments
11.6 Proteome Sciences plc
11.6.1 Proteome Sciences plc Company Information
11.6.2 Proteome Sciences plc Biomarker Clinical Phase Outsourcing Services Product Offered
11.6.3 Proteome Sciences plc Biomarker Clinical Phase Outsourcing Services Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Proteome Sciences plc Main Business Overview
11.6.5 Proteome Sciences plc Latest Developments
11.7 Eurofins Scientific
11.7.1 Eurofins Scientific Company Information
11.7.2 Eurofins Scientific Biomarker Clinical Phase Outsourcing Services Product Offered
11.7.3 Eurofins Scientific Biomarker Clinical Phase Outsourcing Services Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Eurofins Scientific Main Business Overview
11.7.5 Eurofins Scientific Latest Developments
11.8 Wuxi AppTec Co., Ltd.
11.8.1 Wuxi AppTec Co., Ltd. Company Information
11.8.2 Wuxi AppTec Co., Ltd. Biomarker Clinical Phase Outsourcing Services Product Offered
11.8.3 Wuxi AppTec Co., Ltd. Biomarker Clinical Phase Outsourcing Services Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Wuxi AppTec Co., Ltd. Main Business Overview
11.8.5 Wuxi AppTec Co., Ltd. Latest Developments
11.9 NorthEast BioAnalytical Laboratories LLC.
11.9.1 NorthEast BioAnalytical Laboratories LLC. Company Information
11.9.2 NorthEast BioAnalytical Laboratories LLC. Biomarker Clinical Phase Outsourcing Services Product Offered
11.9.3 NorthEast BioAnalytical Laboratories LLC. Biomarker Clinical Phase Outsourcing Services Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 NorthEast BioAnalytical Laboratories LLC. Main Business Overview
11.9.5 NorthEast BioAnalytical Laboratories LLC. Latest Developments
11.10 Celerion, Inc.
11.10.1 Celerion, Inc. Company Information
11.10.2 Celerion, Inc. Biomarker Clinical Phase Outsourcing Services Product Offered
11.10.3 Celerion, Inc. Biomarker Clinical Phase Outsourcing Services Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Celerion, Inc. Main Business Overview
11.10.5 Celerion, Inc. Latest Developments
11.11 GenScript ProBio Co.,Ltd.
11.11.1 GenScript ProBio Co.,Ltd. Company Information
11.11.2 GenScript ProBio Co.,Ltd. Biomarker Clinical Phase Outsourcing Services Product Offered
11.11.3 GenScript ProBio Co.,Ltd. Biomarker Clinical Phase Outsourcing Services Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 GenScript ProBio Co.,Ltd. Main Business Overview
11.11.5 GenScript ProBio Co.,Ltd. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Biomarker Clinical Phase Outsourcing Services Market Size (2021-2032)
2.1.2 Biomarker Clinical Phase Outsourcing Services Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Biomarker Clinical Phase Outsourcing Services by Country/Region (2021, 2025 & 2032)
2.2 Biomarker Clinical Phase Outsourcing Services Segment by Type
2.2.1 Predictive Biomarker
2.2.2 Prognostic Biomarker
2.2.3 Safety Biomarker
2.2.4 Surrogate Endpoints
2.2.5 Biomarker Clinical Phase Outsourcing Services Market Size by Type
2.2.5.1 Biomarker Clinical Phase Outsourcing Services Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.5.2 Global Biomarker Clinical Phase Outsourcing Services Market Size Market Share by Type (2021-2026)
2.3 Biomarker Clinical Phase Outsourcing Services Segment by Application
2.3.1 Pharmaceutical Companies
2.3.2 Biotechnology Companies
2.3.3 Others
2.3.4 Biomarker Clinical Phase Outsourcing Services Market Size by Application
2.3.4.1 Biomarker Clinical Phase Outsourcing Services Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Biomarker Clinical Phase Outsourcing Services Market Size Market Share by Application (2021-2026)
3 BIOMARKER CLINICAL PHASE OUTSOURCING SERVICES MARKET SIZE BY PLAYER
3.1 Biomarker Clinical Phase Outsourcing Services Market Size Market Share by Player
3.1.1 Global Biomarker Clinical Phase Outsourcing Services Revenue by Player (2021-2026)
3.1.2 Global Biomarker Clinical Phase Outsourcing Services Revenue Market Share by Player (2021-2026)
3.2 Global Biomarker Clinical Phase Outsourcing Services Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 BIOMARKER CLINICAL PHASE OUTSOURCING SERVICES BY REGION
4.1 Biomarker Clinical Phase Outsourcing Services Market Size by Region (2021-2026)
4.2 Global Biomarker Clinical Phase Outsourcing Services Annual Revenue by Country/Region (2021-2026)
4.3 Americas Biomarker Clinical Phase Outsourcing Services Market Size Growth (2021-2026)
4.4 APAC Biomarker Clinical Phase Outsourcing Services Market Size Growth (2021-2026)
4.5 Europe Biomarker Clinical Phase Outsourcing Services Market Size Growth (2021-2026)
4.6 Middle East & Africa Biomarker Clinical Phase Outsourcing Services Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Biomarker Clinical Phase Outsourcing Services Market Size by Country (2021-2026)
5.2 Americas Biomarker Clinical Phase Outsourcing Services Market Size by Type (2021-2026)
5.3 Americas Biomarker Clinical Phase Outsourcing Services Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biomarker Clinical Phase Outsourcing Services Market Size by Region (2021-2026)
6.2 APAC Biomarker Clinical Phase Outsourcing Services Market Size by Type (2021-2026)
6.3 APAC Biomarker Clinical Phase Outsourcing Services Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Biomarker Clinical Phase Outsourcing Services Market Size by Country (2021-2026)
7.2 Europe Biomarker Clinical Phase Outsourcing Services Market Size by Type (2021-2026)
7.3 Europe Biomarker Clinical Phase Outsourcing Services Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Biomarker Clinical Phase Outsourcing Services by Region (2021-2026)
8.2 Middle East & Africa Biomarker Clinical Phase Outsourcing Services Market Size by Type (2021-2026)
8.3 Middle East & Africa Biomarker Clinical Phase Outsourcing Services Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL BIOMARKER CLINICAL PHASE OUTSOURCING SERVICES MARKET FORECAST
10.1 Global Biomarker Clinical Phase Outsourcing Services Forecast by Region (2027-2032)
10.1.1 Global Biomarker Clinical Phase Outsourcing Services Forecast by Region (2027-2032)
10.1.2 Americas Biomarker Clinical Phase Outsourcing Services Forecast
10.1.3 APAC Biomarker Clinical Phase Outsourcing Services Forecast
10.1.4 Europe Biomarker Clinical Phase Outsourcing Services Forecast
10.1.5 Middle East & Africa Biomarker Clinical Phase Outsourcing Services Forecast
10.2 Americas Biomarker Clinical Phase Outsourcing Services Forecast by Country (2027-2032)
10.2.1 United States Market Biomarker Clinical Phase Outsourcing Services Forecast
10.2.2 Canada Market Biomarker Clinical Phase Outsourcing Services Forecast
10.2.3 Mexico Market Biomarker Clinical Phase Outsourcing Services Forecast
10.2.4 Brazil Market Biomarker Clinical Phase Outsourcing Services Forecast
10.3 APAC Biomarker Clinical Phase Outsourcing Services Forecast by Region (2027-2032)
10.3.1 China Biomarker Clinical Phase Outsourcing Services Market Forecast
10.3.2 Japan Market Biomarker Clinical Phase Outsourcing Services Forecast
10.3.3 Korea Market Biomarker Clinical Phase Outsourcing Services Forecast
10.3.4 Southeast Asia Market Biomarker Clinical Phase Outsourcing Services Forecast
10.3.5 India Market Biomarker Clinical Phase Outsourcing Services Forecast
10.3.6 Australia Market Biomarker Clinical Phase Outsourcing Services Forecast
10.4 Europe Biomarker Clinical Phase Outsourcing Services Forecast by Country (2027-2032)
10.4.1 Germany Market Biomarker Clinical Phase Outsourcing Services Forecast
10.4.2 France Market Biomarker Clinical Phase Outsourcing Services Forecast
10.4.3 UK Market Biomarker Clinical Phase Outsourcing Services Forecast
10.4.4 Italy Market Biomarker Clinical Phase Outsourcing Services Forecast
10.4.5 Russia Market Biomarker Clinical Phase Outsourcing Services Forecast
10.5 Middle East & Africa Biomarker Clinical Phase Outsourcing Services Forecast by Region (2027-2032)
10.5.1 Egypt Market Biomarker Clinical Phase Outsourcing Services Forecast
10.5.2 South Africa Market Biomarker Clinical Phase Outsourcing Services Forecast
10.5.3 Israel Market Biomarker Clinical Phase Outsourcing Services Forecast
10.5.4 Turkey Market Biomarker Clinical Phase Outsourcing Services Forecast
10.6 Global Biomarker Clinical Phase Outsourcing Services Forecast by Type (2027-2032)
10.7 Global Biomarker Clinical Phase Outsourcing Services Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Biomarker Clinical Phase Outsourcing Services Forecast
11 KEY PLAYERS ANALYSIS
11.1 ICON plc
11.1.1 ICON plc Company Information
11.1.2 ICON plc Biomarker Clinical Phase Outsourcing Services Product Offered
11.1.3 ICON plc Biomarker Clinical Phase Outsourcing Services Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 ICON plc Main Business Overview
11.1.5 ICON plc Latest Developments
11.2 Fujirebio lnc
11.2.1 Fujirebio lnc Company Information
11.2.2 Fujirebio lnc Biomarker Clinical Phase Outsourcing Services Product Offered
11.2.3 Fujirebio lnc Biomarker Clinical Phase Outsourcing Services Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Fujirebio lnc Main Business Overview
11.2.5 Fujirebio lnc Latest Developments
11.3 Charles River Laboratories International,Inc.
11.3.1 Charles River Laboratories International,Inc. Company Information
11.3.2 Charles River Laboratories International,Inc. Biomarker Clinical Phase Outsourcing Services Product Offered
11.3.3 Charles River Laboratories International,Inc. Biomarker Clinical Phase Outsourcing Services Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Charles River Laboratories International,Inc. Main Business Overview
11.3.5 Charles River Laboratories International,Inc. Latest Developments
11.4 Laboratory Corporation of America Holdings
11.4.1 Laboratory Corporation of America Holdings Company Information
11.4.2 Laboratory Corporation of America Holdings Biomarker Clinical Phase Outsourcing Services Product Offered
11.4.3 Laboratory Corporation of America Holdings Biomarker Clinical Phase Outsourcing Services Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Laboratory Corporation of America Holdings Main Business Overview
11.4.5 Laboratory Corporation of America Holdings Latest Developments
11.5 Parexel lnternational Corporation
11.5.1 Parexel lnternational Corporation Company Information
11.5.2 Parexel lnternational Corporation Biomarker Clinical Phase Outsourcing Services Product Offered
11.5.3 Parexel lnternational Corporation Biomarker Clinical Phase Outsourcing Services Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Parexel lnternational Corporation Main Business Overview
11.5.5 Parexel lnternational Corporation Latest Developments
11.6 Proteome Sciences plc
11.6.1 Proteome Sciences plc Company Information
11.6.2 Proteome Sciences plc Biomarker Clinical Phase Outsourcing Services Product Offered
11.6.3 Proteome Sciences plc Biomarker Clinical Phase Outsourcing Services Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Proteome Sciences plc Main Business Overview
11.6.5 Proteome Sciences plc Latest Developments
11.7 Eurofins Scientific
11.7.1 Eurofins Scientific Company Information
11.7.2 Eurofins Scientific Biomarker Clinical Phase Outsourcing Services Product Offered
11.7.3 Eurofins Scientific Biomarker Clinical Phase Outsourcing Services Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Eurofins Scientific Main Business Overview
11.7.5 Eurofins Scientific Latest Developments
11.8 Wuxi AppTec Co., Ltd.
11.8.1 Wuxi AppTec Co., Ltd. Company Information
11.8.2 Wuxi AppTec Co., Ltd. Biomarker Clinical Phase Outsourcing Services Product Offered
11.8.3 Wuxi AppTec Co., Ltd. Biomarker Clinical Phase Outsourcing Services Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Wuxi AppTec Co., Ltd. Main Business Overview
11.8.5 Wuxi AppTec Co., Ltd. Latest Developments
11.9 NorthEast BioAnalytical Laboratories LLC.
11.9.1 NorthEast BioAnalytical Laboratories LLC. Company Information
11.9.2 NorthEast BioAnalytical Laboratories LLC. Biomarker Clinical Phase Outsourcing Services Product Offered
11.9.3 NorthEast BioAnalytical Laboratories LLC. Biomarker Clinical Phase Outsourcing Services Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 NorthEast BioAnalytical Laboratories LLC. Main Business Overview
11.9.5 NorthEast BioAnalytical Laboratories LLC. Latest Developments
11.10 Celerion, Inc.
11.10.1 Celerion, Inc. Company Information
11.10.2 Celerion, Inc. Biomarker Clinical Phase Outsourcing Services Product Offered
11.10.3 Celerion, Inc. Biomarker Clinical Phase Outsourcing Services Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Celerion, Inc. Main Business Overview
11.10.5 Celerion, Inc. Latest Developments
11.11 GenScript ProBio Co.,Ltd.
11.11.1 GenScript ProBio Co.,Ltd. Company Information
11.11.2 GenScript ProBio Co.,Ltd. Biomarker Clinical Phase Outsourcing Services Product Offered
11.11.3 GenScript ProBio Co.,Ltd. Biomarker Clinical Phase Outsourcing Services Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 GenScript ProBio Co.,Ltd. Main Business Overview
11.11.5 GenScript ProBio Co.,Ltd. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Biomarker Clinical Phase Outsourcing Services Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Biomarker Clinical Phase Outsourcing Services Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Predictive Biomarker
Table 4. Major Players of Prognostic Biomarker
Table 5. Major Players of Safety Biomarker
Table 6. Major Players of Surrogate Endpoints
Table 7. Biomarker Clinical Phase Outsourcing Services Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global Biomarker Clinical Phase Outsourcing Services Market Size by Type (2021-2026) & ($ millions)
Table 9. Global Biomarker Clinical Phase Outsourcing Services Market Size Market Share by Type (2021-2026)
Table 10. Biomarker Clinical Phase Outsourcing Services Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 11. Global Biomarker Clinical Phase Outsourcing Services Market Size by Application (2021-2026) & ($ millions)
Table 12. Global Biomarker Clinical Phase Outsourcing Services Market Size Market Share by Application (2021-2026)
Table 13. Global Biomarker Clinical Phase Outsourcing Services Revenue by Player (2021-2026) & ($ millions)
Table 14. Global Biomarker Clinical Phase Outsourcing Services Revenue Market Share by Player (2021-2026)
Table 15. Biomarker Clinical Phase Outsourcing Services Key Players Head office and Products Offered
Table 16. Biomarker Clinical Phase Outsourcing Services Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Biomarker Clinical Phase Outsourcing Services Market Size by Region (2021-2026) & ($ millions)
Table 20. Global Biomarker Clinical Phase Outsourcing Services Market Size Market Share by Region (2021-2026)
Table 21. Global Biomarker Clinical Phase Outsourcing Services Revenue by Country/Region (2021-2026) & ($ millions)
Table 22. Global Biomarker Clinical Phase Outsourcing Services Revenue Market Share by Country/Region (2021-2026)
Table 23. Americas Biomarker Clinical Phase Outsourcing Services Market Size by Country (2021-2026) & ($ millions)
Table 24. Americas Biomarker Clinical Phase Outsourcing Services Market Size Market Share by Country (2021-2026)
Table 25. Americas Biomarker Clinical Phase Outsourcing Services Market Size by Type (2021-2026) & ($ millions)
Table 26. Americas Biomarker Clinical Phase Outsourcing Services Market Size Market Share by Type (2021-2026)
Table 27. Americas Biomarker Clinical Phase Outsourcing Services Market Size by Application (2021-2026) & ($ millions)
Table 28. Americas Biomarker Clinical Phase Outsourcing Services Market Size Market Share by Application (2021-2026)
Table 29. APAC Biomarker Clinical Phase Outsourcing Services Market Size by Region (2021-2026) & ($ millions)
Table 30. APAC Biomarker Clinical Phase Outsourcing Services Market Size Market Share by Region (2021-2026)
Table 31. APAC Biomarker Clinical Phase Outsourcing Services Market Size by Type (2021-2026) & ($ millions)
Table 32. APAC Biomarker Clinical Phase Outsourcing Services Market Size by Application (2021-2026) & ($ millions)
Table 33. Europe Biomarker Clinical Phase Outsourcing Services Market Size by Country (2021-2026) & ($ millions)
Table 34. Europe Biomarker Clinical Phase Outsourcing Services Market Size Market Share by Country (2021-2026)
Table 35. Europe Biomarker Clinical Phase Outsourcing Services Market Size by Type (2021-2026) & ($ millions)
Table 36. Europe Biomarker Clinical Phase Outsourcing Services Market Size by Application (2021-2026) & ($ millions)
Table 37. Middle East & Africa Biomarker Clinical Phase Outsourcing Services Market Size by Region (2021-2026) & ($ millions)
Table 38. Middle East & Africa Biomarker Clinical Phase Outsourcing Services Market Size by Type (2021-2026) & ($ millions)
Table 39. Middle East & Africa Biomarker Clinical Phase Outsourcing Services Market Size by Application (2021-2026) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Biomarker Clinical Phase Outsourcing Services
Table 41. Key Market Challenges & Risks of Biomarker Clinical Phase Outsourcing Services
Table 42. Key Industry Trends of Biomarker Clinical Phase Outsourcing Services
Table 43. Global Biomarker Clinical Phase Outsourcing Services Market Size Forecast by Region (2027-2032) & ($ millions)
Table 44. Global Biomarker Clinical Phase Outsourcing Services Market Size Market Share Forecast by Region (2027-2032)
Table 45. Global Biomarker Clinical Phase Outsourcing Services Market Size Forecast by Type (2027-2032) & ($ millions)
Table 46. Global Biomarker Clinical Phase Outsourcing Services Market Size Forecast by Application (2027-2032) & ($ millions)
Table 47. ICON plc Details, Company Type, Biomarker Clinical Phase Outsourcing Services Area Served and Its Competitors
Table 48. ICON plc Biomarker Clinical Phase Outsourcing Services Product Offered
Table 49. ICON plc Biomarker Clinical Phase Outsourcing Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 50. ICON plc Main Business
Table 51. ICON plc Latest Developments
Table 52. Fujirebio lnc Details, Company Type, Biomarker Clinical Phase Outsourcing Services Area Served and Its Competitors
Table 53. Fujirebio lnc Biomarker Clinical Phase Outsourcing Services Product Offered
Table 54. Fujirebio lnc Biomarker Clinical Phase Outsourcing Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 55. Fujirebio lnc Main Business
Table 56. Fujirebio lnc Latest Developments
Table 57. Charles River Laboratories International,Inc. Details, Company Type, Biomarker Clinical Phase Outsourcing Services Area Served and Its Competitors
Table 58. Charles River Laboratories International,Inc. Biomarker Clinical Phase Outsourcing Services Product Offered
Table 59. Charles River Laboratories International,Inc. Biomarker Clinical Phase Outsourcing Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 60. Charles River Laboratories International,Inc. Main Business
Table 61. Charles River Laboratories International,Inc. Latest Developments
Table 62. Laboratory Corporation of America Holdings Details, Company Type, Biomarker Clinical Phase Outsourcing Services Area Served and Its Competitors
Table 63. Laboratory Corporation of America Holdings Biomarker Clinical Phase Outsourcing Services Product Offered
Table 64. Laboratory Corporation of America Holdings Biomarker Clinical Phase Outsourcing Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 65. Laboratory Corporation of America Holdings Main Business
Table 66. Laboratory Corporation of America Holdings Latest Developments
Table 67. Parexel lnternational Corporation Details, Company Type, Biomarker Clinical Phase Outsourcing Services Area Served and Its Competitors
Table 68. Parexel lnternational Corporation Biomarker Clinical Phase Outsourcing Services Product Offered
Table 69. Parexel lnternational Corporation Biomarker Clinical Phase Outsourcing Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 70. Parexel lnternational Corporation Main Business
Table 71. Parexel lnternational Corporation Latest Developments
Table 72. Proteome Sciences plc Details, Company Type, Biomarker Clinical Phase Outsourcing Services Area Served and Its Competitors
Table 73. Proteome Sciences plc Biomarker Clinical Phase Outsourcing Services Product Offered
Table 74. Proteome Sciences plc Biomarker Clinical Phase Outsourcing Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 75. Proteome Sciences plc Main Business
Table 76. Proteome Sciences plc Latest Developments
Table 77. Eurofins Scientific Details, Company Type, Biomarker Clinical Phase Outsourcing Services Area Served and Its Competitors
Table 78. Eurofins Scientific Biomarker Clinical Phase Outsourcing Services Product Offered
Table 79. Eurofins Scientific Biomarker Clinical Phase Outsourcing Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 80. Eurofins Scientific Main Business
Table 81. Eurofins Scientific Latest Developments
Table 82. Wuxi AppTec Co., Ltd. Details, Company Type, Biomarker Clinical Phase Outsourcing Services Area Served and Its Competitors
Table 83. Wuxi AppTec Co., Ltd. Biomarker Clinical Phase Outsourcing Services Product Offered
Table 84. Wuxi AppTec Co., Ltd. Biomarker Clinical Phase Outsourcing Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 85. Wuxi AppTec Co., Ltd. Main Business
Table 86. Wuxi AppTec Co., Ltd. Latest Developments
Table 87. NorthEast BioAnalytical Laboratories LLC. Details, Company Type, Biomarker Clinical Phase Outsourcing Services Area Served and Its Competitors
Table 88. NorthEast BioAnalytical Laboratories LLC. Biomarker Clinical Phase Outsourcing Services Product Offered
Table 89. NorthEast BioAnalytical Laboratories LLC. Biomarker Clinical Phase Outsourcing Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 90. NorthEast BioAnalytical Laboratories LLC. Main Business
Table 91. NorthEast BioAnalytical Laboratories LLC. Latest Developments
Table 92. Celerion, Inc. Details, Company Type, Biomarker Clinical Phase Outsourcing Services Area Served and Its Competitors
Table 93. Celerion, Inc. Biomarker Clinical Phase Outsourcing Services Product Offered
Table 94. Celerion, Inc. Biomarker Clinical Phase Outsourcing Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 95. Celerion, Inc. Main Business
Table 96. Celerion, Inc. Latest Developments
Table 97. GenScript ProBio Co.,Ltd. Details, Company Type, Biomarker Clinical Phase Outsourcing Services Area Served and Its Competitors
Table 98. GenScript ProBio Co.,Ltd. Biomarker Clinical Phase Outsourcing Services Product Offered
Table 99. GenScript ProBio Co.,Ltd. Biomarker Clinical Phase Outsourcing Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 100. GenScript ProBio Co.,Ltd. Main Business
Table 101. GenScript ProBio Co.,Ltd. Latest Developments
Table 1. Biomarker Clinical Phase Outsourcing Services Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Biomarker Clinical Phase Outsourcing Services Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Predictive Biomarker
Table 4. Major Players of Prognostic Biomarker
Table 5. Major Players of Safety Biomarker
Table 6. Major Players of Surrogate Endpoints
Table 7. Biomarker Clinical Phase Outsourcing Services Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global Biomarker Clinical Phase Outsourcing Services Market Size by Type (2021-2026) & ($ millions)
Table 9. Global Biomarker Clinical Phase Outsourcing Services Market Size Market Share by Type (2021-2026)
Table 10. Biomarker Clinical Phase Outsourcing Services Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 11. Global Biomarker Clinical Phase Outsourcing Services Market Size by Application (2021-2026) & ($ millions)
Table 12. Global Biomarker Clinical Phase Outsourcing Services Market Size Market Share by Application (2021-2026)
Table 13. Global Biomarker Clinical Phase Outsourcing Services Revenue by Player (2021-2026) & ($ millions)
Table 14. Global Biomarker Clinical Phase Outsourcing Services Revenue Market Share by Player (2021-2026)
Table 15. Biomarker Clinical Phase Outsourcing Services Key Players Head office and Products Offered
Table 16. Biomarker Clinical Phase Outsourcing Services Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Biomarker Clinical Phase Outsourcing Services Market Size by Region (2021-2026) & ($ millions)
Table 20. Global Biomarker Clinical Phase Outsourcing Services Market Size Market Share by Region (2021-2026)
Table 21. Global Biomarker Clinical Phase Outsourcing Services Revenue by Country/Region (2021-2026) & ($ millions)
Table 22. Global Biomarker Clinical Phase Outsourcing Services Revenue Market Share by Country/Region (2021-2026)
Table 23. Americas Biomarker Clinical Phase Outsourcing Services Market Size by Country (2021-2026) & ($ millions)
Table 24. Americas Biomarker Clinical Phase Outsourcing Services Market Size Market Share by Country (2021-2026)
Table 25. Americas Biomarker Clinical Phase Outsourcing Services Market Size by Type (2021-2026) & ($ millions)
Table 26. Americas Biomarker Clinical Phase Outsourcing Services Market Size Market Share by Type (2021-2026)
Table 27. Americas Biomarker Clinical Phase Outsourcing Services Market Size by Application (2021-2026) & ($ millions)
Table 28. Americas Biomarker Clinical Phase Outsourcing Services Market Size Market Share by Application (2021-2026)
Table 29. APAC Biomarker Clinical Phase Outsourcing Services Market Size by Region (2021-2026) & ($ millions)
Table 30. APAC Biomarker Clinical Phase Outsourcing Services Market Size Market Share by Region (2021-2026)
Table 31. APAC Biomarker Clinical Phase Outsourcing Services Market Size by Type (2021-2026) & ($ millions)
Table 32. APAC Biomarker Clinical Phase Outsourcing Services Market Size by Application (2021-2026) & ($ millions)
Table 33. Europe Biomarker Clinical Phase Outsourcing Services Market Size by Country (2021-2026) & ($ millions)
Table 34. Europe Biomarker Clinical Phase Outsourcing Services Market Size Market Share by Country (2021-2026)
Table 35. Europe Biomarker Clinical Phase Outsourcing Services Market Size by Type (2021-2026) & ($ millions)
Table 36. Europe Biomarker Clinical Phase Outsourcing Services Market Size by Application (2021-2026) & ($ millions)
Table 37. Middle East & Africa Biomarker Clinical Phase Outsourcing Services Market Size by Region (2021-2026) & ($ millions)
Table 38. Middle East & Africa Biomarker Clinical Phase Outsourcing Services Market Size by Type (2021-2026) & ($ millions)
Table 39. Middle East & Africa Biomarker Clinical Phase Outsourcing Services Market Size by Application (2021-2026) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Biomarker Clinical Phase Outsourcing Services
Table 41. Key Market Challenges & Risks of Biomarker Clinical Phase Outsourcing Services
Table 42. Key Industry Trends of Biomarker Clinical Phase Outsourcing Services
Table 43. Global Biomarker Clinical Phase Outsourcing Services Market Size Forecast by Region (2027-2032) & ($ millions)
Table 44. Global Biomarker Clinical Phase Outsourcing Services Market Size Market Share Forecast by Region (2027-2032)
Table 45. Global Biomarker Clinical Phase Outsourcing Services Market Size Forecast by Type (2027-2032) & ($ millions)
Table 46. Global Biomarker Clinical Phase Outsourcing Services Market Size Forecast by Application (2027-2032) & ($ millions)
Table 47. ICON plc Details, Company Type, Biomarker Clinical Phase Outsourcing Services Area Served and Its Competitors
Table 48. ICON plc Biomarker Clinical Phase Outsourcing Services Product Offered
Table 49. ICON plc Biomarker Clinical Phase Outsourcing Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 50. ICON plc Main Business
Table 51. ICON plc Latest Developments
Table 52. Fujirebio lnc Details, Company Type, Biomarker Clinical Phase Outsourcing Services Area Served and Its Competitors
Table 53. Fujirebio lnc Biomarker Clinical Phase Outsourcing Services Product Offered
Table 54. Fujirebio lnc Biomarker Clinical Phase Outsourcing Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 55. Fujirebio lnc Main Business
Table 56. Fujirebio lnc Latest Developments
Table 57. Charles River Laboratories International,Inc. Details, Company Type, Biomarker Clinical Phase Outsourcing Services Area Served and Its Competitors
Table 58. Charles River Laboratories International,Inc. Biomarker Clinical Phase Outsourcing Services Product Offered
Table 59. Charles River Laboratories International,Inc. Biomarker Clinical Phase Outsourcing Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 60. Charles River Laboratories International,Inc. Main Business
Table 61. Charles River Laboratories International,Inc. Latest Developments
Table 62. Laboratory Corporation of America Holdings Details, Company Type, Biomarker Clinical Phase Outsourcing Services Area Served and Its Competitors
Table 63. Laboratory Corporation of America Holdings Biomarker Clinical Phase Outsourcing Services Product Offered
Table 64. Laboratory Corporation of America Holdings Biomarker Clinical Phase Outsourcing Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 65. Laboratory Corporation of America Holdings Main Business
Table 66. Laboratory Corporation of America Holdings Latest Developments
Table 67. Parexel lnternational Corporation Details, Company Type, Biomarker Clinical Phase Outsourcing Services Area Served and Its Competitors
Table 68. Parexel lnternational Corporation Biomarker Clinical Phase Outsourcing Services Product Offered
Table 69. Parexel lnternational Corporation Biomarker Clinical Phase Outsourcing Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 70. Parexel lnternational Corporation Main Business
Table 71. Parexel lnternational Corporation Latest Developments
Table 72. Proteome Sciences plc Details, Company Type, Biomarker Clinical Phase Outsourcing Services Area Served and Its Competitors
Table 73. Proteome Sciences plc Biomarker Clinical Phase Outsourcing Services Product Offered
Table 74. Proteome Sciences plc Biomarker Clinical Phase Outsourcing Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 75. Proteome Sciences plc Main Business
Table 76. Proteome Sciences plc Latest Developments
Table 77. Eurofins Scientific Details, Company Type, Biomarker Clinical Phase Outsourcing Services Area Served and Its Competitors
Table 78. Eurofins Scientific Biomarker Clinical Phase Outsourcing Services Product Offered
Table 79. Eurofins Scientific Biomarker Clinical Phase Outsourcing Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 80. Eurofins Scientific Main Business
Table 81. Eurofins Scientific Latest Developments
Table 82. Wuxi AppTec Co., Ltd. Details, Company Type, Biomarker Clinical Phase Outsourcing Services Area Served and Its Competitors
Table 83. Wuxi AppTec Co., Ltd. Biomarker Clinical Phase Outsourcing Services Product Offered
Table 84. Wuxi AppTec Co., Ltd. Biomarker Clinical Phase Outsourcing Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 85. Wuxi AppTec Co., Ltd. Main Business
Table 86. Wuxi AppTec Co., Ltd. Latest Developments
Table 87. NorthEast BioAnalytical Laboratories LLC. Details, Company Type, Biomarker Clinical Phase Outsourcing Services Area Served and Its Competitors
Table 88. NorthEast BioAnalytical Laboratories LLC. Biomarker Clinical Phase Outsourcing Services Product Offered
Table 89. NorthEast BioAnalytical Laboratories LLC. Biomarker Clinical Phase Outsourcing Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 90. NorthEast BioAnalytical Laboratories LLC. Main Business
Table 91. NorthEast BioAnalytical Laboratories LLC. Latest Developments
Table 92. Celerion, Inc. Details, Company Type, Biomarker Clinical Phase Outsourcing Services Area Served and Its Competitors
Table 93. Celerion, Inc. Biomarker Clinical Phase Outsourcing Services Product Offered
Table 94. Celerion, Inc. Biomarker Clinical Phase Outsourcing Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 95. Celerion, Inc. Main Business
Table 96. Celerion, Inc. Latest Developments
Table 97. GenScript ProBio Co.,Ltd. Details, Company Type, Biomarker Clinical Phase Outsourcing Services Area Served and Its Competitors
Table 98. GenScript ProBio Co.,Ltd. Biomarker Clinical Phase Outsourcing Services Product Offered
Table 99. GenScript ProBio Co.,Ltd. Biomarker Clinical Phase Outsourcing Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 100. GenScript ProBio Co.,Ltd. Main Business
Table 101. GenScript ProBio Co.,Ltd. Latest Developments
LIST OF FIGURES
Figure 1. Biomarker Clinical Phase Outsourcing Services Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Biomarker Clinical Phase Outsourcing Services Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Biomarker Clinical Phase Outsourcing Services Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Biomarker Clinical Phase Outsourcing Services Sales Market Share by Country/Region (2025)
Figure 8. Biomarker Clinical Phase Outsourcing Services Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Biomarker Clinical Phase Outsourcing Services Market Size Market Share by Type in 2025
Figure 10. Biomarker Clinical Phase Outsourcing Services in Pharmaceutical Companies
Figure 11. Global Biomarker Clinical Phase Outsourcing Services Market: Pharmaceutical Companies (2021-2026) & ($ millions)
Figure 12. Biomarker Clinical Phase Outsourcing Services in Biotechnology Companies
Figure 13. Global Biomarker Clinical Phase Outsourcing Services Market: Biotechnology Companies (2021-2026) & ($ millions)
Figure 14. Biomarker Clinical Phase Outsourcing Services in Others
Figure 15. Global Biomarker Clinical Phase Outsourcing Services Market: Others (2021-2026) & ($ millions)
Figure 16. Global Biomarker Clinical Phase Outsourcing Services Market Size Market Share by Application in 2025
Figure 17. Global Biomarker Clinical Phase Outsourcing Services Revenue Market Share by Player in 2025
Figure 18. Global Biomarker Clinical Phase Outsourcing Services Market Size Market Share by Region (2021-2026)
Figure 19. Americas Biomarker Clinical Phase Outsourcing Services Market Size 2021-2026 ($ millions)
Figure 20. APAC Biomarker Clinical Phase Outsourcing Services Market Size 2021-2026 ($ millions)
Figure 21. Europe Biomarker Clinical Phase Outsourcing Services Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Biomarker Clinical Phase Outsourcing Services Market Size 2021-2026 ($ millions)
Figure 23. Americas Biomarker Clinical Phase Outsourcing Services Value Market Share by Country in 2025
Figure 24. United States Biomarker Clinical Phase Outsourcing Services Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Biomarker Clinical Phase Outsourcing Services Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Biomarker Clinical Phase Outsourcing Services Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Biomarker Clinical Phase Outsourcing Services Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Biomarker Clinical Phase Outsourcing Services Market Size Market Share by Region in 2025
Figure 29. APAC Biomarker Clinical Phase Outsourcing Services Market Size Market Share by Type (2021-2026)
Figure 30. APAC Biomarker Clinical Phase Outsourcing Services Market Size Market Share by Application (2021-2026)
Figure 31. China Biomarker Clinical Phase Outsourcing Services Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Biomarker Clinical Phase Outsourcing Services Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Biomarker Clinical Phase Outsourcing Services Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Biomarker Clinical Phase Outsourcing Services Market Size Growth 2021-2026 ($ millions)
Figure 35. India Biomarker Clinical Phase Outsourcing Services Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Biomarker Clinical Phase Outsourcing Services Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Biomarker Clinical Phase Outsourcing Services Market Size Market Share by Country in 2025
Figure 38. Europe Biomarker Clinical Phase Outsourcing Services Market Size Market Share by Type (2021-2026)
Figure 39. Europe Biomarker Clinical Phase Outsourcing Services Market Size Market Share by Application (2021-2026)
Figure 40. Germany Biomarker Clinical Phase Outsourcing Services Market Size Growth 2021-2026 ($ millions)
Figure 41. France Biomarker Clinical Phase Outsourcing Services Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Biomarker Clinical Phase Outsourcing Services Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Biomarker Clinical Phase Outsourcing Services Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Biomarker Clinical Phase Outsourcing Services Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Biomarker Clinical Phase Outsourcing Services Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Biomarker Clinical Phase Outsourcing Services Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Biomarker Clinical Phase Outsourcing Services Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Biomarker Clinical Phase Outsourcing Services Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Biomarker Clinical Phase Outsourcing Services Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Biomarker Clinical Phase Outsourcing Services Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Biomarker Clinical Phase Outsourcing Services Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Biomarker Clinical Phase Outsourcing Services Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Biomarker Clinical Phase Outsourcing Services Market Size 2027-2032 ($ millions)
Figure 54. APAC Biomarker Clinical Phase Outsourcing Services Market Size 2027-2032 ($ millions)
Figure 55. Europe Biomarker Clinical Phase Outsourcing Services Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Biomarker Clinical Phase Outsourcing Services Market Size 2027-2032 ($ millions)
Figure 57. United States Biomarker Clinical Phase Outsourcing Services Market Size 2027-2032 ($ millions)
Figure 58. Canada Biomarker Clinical Phase Outsourcing Services Market Size 2027-2032 ($ millions)
Figure 59. Mexico Biomarker Clinical Phase Outsourcing Services Market Size 2027-2032 ($ millions)
Figure 60. Brazil Biomarker Clinical Phase Outsourcing Services Market Size 2027-2032 ($ millions)
Figure 61. China Biomarker Clinical Phase Outsourcing Services Market Size 2027-2032 ($ millions)
Figure 62. Japan Biomarker Clinical Phase Outsourcing Services Market Size 2027-2032 ($ millions)
Figure 63. Korea Biomarker Clinical Phase Outsourcing Services Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Biomarker Clinical Phase Outsourcing Services Market Size 2027-2032 ($ millions)
Figure 65. India Biomarker Clinical Phase Outsourcing Services Market Size 2027-2032 ($ millions)
Figure 66. Australia Biomarker Clinical Phase Outsourcing Services Market Size 2027-2032 ($ millions)
Figure 67. Germany Biomarker Clinical Phase Outsourcing Services Market Size 2027-2032 ($ millions)
Figure 68. France Biomarker Clinical Phase Outsourcing Services Market Size 2027-2032 ($ millions)
Figure 69. UK Biomarker Clinical Phase Outsourcing Services Market Size 2027-2032 ($ millions)
Figure 70. Italy Biomarker Clinical Phase Outsourcing Services Market Size 2027-2032 ($ millions)
Figure 71. Russia Biomarker Clinical Phase Outsourcing Services Market Size 2027-2032 ($ millions)
Figure 72. Egypt Biomarker Clinical Phase Outsourcing Services Market Size 2027-2032 ($ millions)
Figure 73. South Africa Biomarker Clinical Phase Outsourcing Services Market Size 2027-2032 ($ millions)
Figure 74. Israel Biomarker Clinical Phase Outsourcing Services Market Size 2027-2032 ($ millions)
Figure 75. Turkey Biomarker Clinical Phase Outsourcing Services Market Size 2027-2032 ($ millions)
Figure 76. Global Biomarker Clinical Phase Outsourcing Services Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Biomarker Clinical Phase Outsourcing Services Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Biomarker Clinical Phase Outsourcing Services Market Size 2027-2032 ($ millions)
Figure 1. Biomarker Clinical Phase Outsourcing Services Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Biomarker Clinical Phase Outsourcing Services Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Biomarker Clinical Phase Outsourcing Services Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Biomarker Clinical Phase Outsourcing Services Sales Market Share by Country/Region (2025)
Figure 8. Biomarker Clinical Phase Outsourcing Services Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Biomarker Clinical Phase Outsourcing Services Market Size Market Share by Type in 2025
Figure 10. Biomarker Clinical Phase Outsourcing Services in Pharmaceutical Companies
Figure 11. Global Biomarker Clinical Phase Outsourcing Services Market: Pharmaceutical Companies (2021-2026) & ($ millions)
Figure 12. Biomarker Clinical Phase Outsourcing Services in Biotechnology Companies
Figure 13. Global Biomarker Clinical Phase Outsourcing Services Market: Biotechnology Companies (2021-2026) & ($ millions)
Figure 14. Biomarker Clinical Phase Outsourcing Services in Others
Figure 15. Global Biomarker Clinical Phase Outsourcing Services Market: Others (2021-2026) & ($ millions)
Figure 16. Global Biomarker Clinical Phase Outsourcing Services Market Size Market Share by Application in 2025
Figure 17. Global Biomarker Clinical Phase Outsourcing Services Revenue Market Share by Player in 2025
Figure 18. Global Biomarker Clinical Phase Outsourcing Services Market Size Market Share by Region (2021-2026)
Figure 19. Americas Biomarker Clinical Phase Outsourcing Services Market Size 2021-2026 ($ millions)
Figure 20. APAC Biomarker Clinical Phase Outsourcing Services Market Size 2021-2026 ($ millions)
Figure 21. Europe Biomarker Clinical Phase Outsourcing Services Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Biomarker Clinical Phase Outsourcing Services Market Size 2021-2026 ($ millions)
Figure 23. Americas Biomarker Clinical Phase Outsourcing Services Value Market Share by Country in 2025
Figure 24. United States Biomarker Clinical Phase Outsourcing Services Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Biomarker Clinical Phase Outsourcing Services Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Biomarker Clinical Phase Outsourcing Services Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Biomarker Clinical Phase Outsourcing Services Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Biomarker Clinical Phase Outsourcing Services Market Size Market Share by Region in 2025
Figure 29. APAC Biomarker Clinical Phase Outsourcing Services Market Size Market Share by Type (2021-2026)
Figure 30. APAC Biomarker Clinical Phase Outsourcing Services Market Size Market Share by Application (2021-2026)
Figure 31. China Biomarker Clinical Phase Outsourcing Services Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Biomarker Clinical Phase Outsourcing Services Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Biomarker Clinical Phase Outsourcing Services Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Biomarker Clinical Phase Outsourcing Services Market Size Growth 2021-2026 ($ millions)
Figure 35. India Biomarker Clinical Phase Outsourcing Services Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Biomarker Clinical Phase Outsourcing Services Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Biomarker Clinical Phase Outsourcing Services Market Size Market Share by Country in 2025
Figure 38. Europe Biomarker Clinical Phase Outsourcing Services Market Size Market Share by Type (2021-2026)
Figure 39. Europe Biomarker Clinical Phase Outsourcing Services Market Size Market Share by Application (2021-2026)
Figure 40. Germany Biomarker Clinical Phase Outsourcing Services Market Size Growth 2021-2026 ($ millions)
Figure 41. France Biomarker Clinical Phase Outsourcing Services Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Biomarker Clinical Phase Outsourcing Services Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Biomarker Clinical Phase Outsourcing Services Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Biomarker Clinical Phase Outsourcing Services Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Biomarker Clinical Phase Outsourcing Services Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Biomarker Clinical Phase Outsourcing Services Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Biomarker Clinical Phase Outsourcing Services Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Biomarker Clinical Phase Outsourcing Services Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Biomarker Clinical Phase Outsourcing Services Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Biomarker Clinical Phase Outsourcing Services Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Biomarker Clinical Phase Outsourcing Services Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Biomarker Clinical Phase Outsourcing Services Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Biomarker Clinical Phase Outsourcing Services Market Size 2027-2032 ($ millions)
Figure 54. APAC Biomarker Clinical Phase Outsourcing Services Market Size 2027-2032 ($ millions)
Figure 55. Europe Biomarker Clinical Phase Outsourcing Services Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Biomarker Clinical Phase Outsourcing Services Market Size 2027-2032 ($ millions)
Figure 57. United States Biomarker Clinical Phase Outsourcing Services Market Size 2027-2032 ($ millions)
Figure 58. Canada Biomarker Clinical Phase Outsourcing Services Market Size 2027-2032 ($ millions)
Figure 59. Mexico Biomarker Clinical Phase Outsourcing Services Market Size 2027-2032 ($ millions)
Figure 60. Brazil Biomarker Clinical Phase Outsourcing Services Market Size 2027-2032 ($ millions)
Figure 61. China Biomarker Clinical Phase Outsourcing Services Market Size 2027-2032 ($ millions)
Figure 62. Japan Biomarker Clinical Phase Outsourcing Services Market Size 2027-2032 ($ millions)
Figure 63. Korea Biomarker Clinical Phase Outsourcing Services Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Biomarker Clinical Phase Outsourcing Services Market Size 2027-2032 ($ millions)
Figure 65. India Biomarker Clinical Phase Outsourcing Services Market Size 2027-2032 ($ millions)
Figure 66. Australia Biomarker Clinical Phase Outsourcing Services Market Size 2027-2032 ($ millions)
Figure 67. Germany Biomarker Clinical Phase Outsourcing Services Market Size 2027-2032 ($ millions)
Figure 68. France Biomarker Clinical Phase Outsourcing Services Market Size 2027-2032 ($ millions)
Figure 69. UK Biomarker Clinical Phase Outsourcing Services Market Size 2027-2032 ($ millions)
Figure 70. Italy Biomarker Clinical Phase Outsourcing Services Market Size 2027-2032 ($ millions)
Figure 71. Russia Biomarker Clinical Phase Outsourcing Services Market Size 2027-2032 ($ millions)
Figure 72. Egypt Biomarker Clinical Phase Outsourcing Services Market Size 2027-2032 ($ millions)
Figure 73. South Africa Biomarker Clinical Phase Outsourcing Services Market Size 2027-2032 ($ millions)
Figure 74. Israel Biomarker Clinical Phase Outsourcing Services Market Size 2027-2032 ($ millions)
Figure 75. Turkey Biomarker Clinical Phase Outsourcing Services Market Size 2027-2032 ($ millions)
Figure 76. Global Biomarker Clinical Phase Outsourcing Services Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Biomarker Clinical Phase Outsourcing Services Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Biomarker Clinical Phase Outsourcing Services Market Size 2027-2032 ($ millions)
